Label: ACNE SPOT TREATMENT- benzoyl peroxide cream

  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: OTC monograph final

DISCLAIMER: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Drug Label Information

Updated April 3, 2023

If you are a consumer or patient please visit this version.

  • ACTIVE INGREDIENT

    Active Ingredient

    Benzoyl Peroxide 5.00%

  • PURPOSE

    Purpose

    Acne Treatment

  • INDICATIONS & USAGE

    Uses

    • For the treatment of acne
  • WARNINGS

    For external use only

    Do not use if

    Do not use if you

    • have very sensitive skin
    • are sensitive to benzoyl peroxide

    When using this product

    • skin irritation and dryness are more likely to occur if you use another topicalk acne medication at the same time. If irritation occurs, only use one topical acne treatment at a time.
    • avoid unnecessary sun exposure and use sunscreen
    • avoid contact with eyes, lips, and mouth.
    • avoid contact with hair and dyed fabrics, which may be bleached by this product.
    • skin irritation may occur, characterized by redness, burning, itching, peeling, or possibly swelling. Irritation may be reduced by using the product less frequently or in a lower concentration.

    Stop use and consult

    Stop use and consult with a doctor if

    • irritation becomes severe.

    Keep out of reach of children

    Keep out of reach of children. If product is swallowed, get medical help or contact a poison control center right away.

  • Directions

    Directions

    • Clean skin thoroughly before applying this product
    • cover the entire affected area with a thin layer one to three times daily
    • because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor.
    • if bothersome dryness or peeling occurs, reduce application to once a day or every other day
    • if going outside. apply sunscreen after using this product. If irritation or sensitivity develops, stop use of both products and sak a doctor.

    Sensitivity Test for a new User. Apply product sparingly to one or two small affected areas during the first 3 days. If no discomfort occurs, follow the directions stated above.

  • INACTIVE INGREDIENT

    Inactive Ingredients

    Water, Isostearyl Alcohol, Glycerin, Pentylene Glycol, Silica, Hamamelis Virginiana (Witch Hazel) Water, Epilobium Angustifolium Flower/Leaf/Stem Extract, Phragmites Communis Extract, Poria Cocos Extract, Niacinamide, Tocopheryl Acetate, Carbomer, Potassium Hydroxide, Acrylates/C10-30 Alkyl Acrylate Crosspolymer, Disodium EDTA.

  • Questions or Comments

    Questions or comments?

    Toll-free number 1-800-878-1978

  • PRIMARY PACKAGE

    Tube

  • OUTER PACKAGE

    Outer package

  • INGREDIENTS AND APPEARANCE
    ACNE SPOT TREATMENT 
    benzoyl peroxide cream
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:78518-013
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    BENZOYL PEROXIDE (UNII: W9WZN9A0GM) (BENZOYL PEROXIDE - UNII:W9WZN9A0GM) BENZOYL PEROXIDE5 mg  in 100 mg
    Inactive Ingredients
    Ingredient NameStrength
    GLYCERIN (UNII: PDC6A3C0OX)  
    WATER (UNII: 059QF0KO0R)  
    NIACINAMIDE (UNII: 25X51I8RD4)  
    SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
    POTASSIUM HYDROXIDE (UNII: WZH3C48M4T)  
    CARBOMER COPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED) (UNII: 809Y72KV36)  
    DISODIUM EDTA-COPPER (UNII: 6V475AX06U)  
    PENTYLENE GLYCOL (UNII: 50C1307PZG)  
    ISOSTEARYL ALCOHOL (UNII: Q613OCQ44Y)  
    EPILOBIUM ANGUSTIFOLIUM LEAF (UNII: 7NV86426N2)  
    HAMAMELIS VIRGINIANA LEAF WATER (UNII: 8FP93ED6H2)  
    FU LING (UNII: XH37TWY5O4)  
    ALPHA-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0)  
    CARBOMER HOMOPOLYMER, UNSPECIFIED TYPE (UNII: 0A5MM307FC)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:78518-013-011 in 1 CARTON04/04/2023
    115 mg in 1 TUBE; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC monograph finalM00604/04/2023
    Labeler - MONAT GLOBAL CORP (027036949)
    Establishment
    NameAddressID/FEIBusiness Operations
    Dermacare MFG116817470manufacture(78518-013)